Study Stopped
Lack of enrollment
Eye Movements and Reading Disabilities
EOMRD
Reliability of Clinical Eye Movement Tests as Screening Devices for Reading Disabilities
1 other identifier
observational
1
1 country
1
Brief Summary
The mechanism of the eye movement anomalies seen in dyslexic patients is not well defined. Some optometrists use observational eye movement tests as screening devices for dyslexia and advocate eye movement therapy as a treatment option for dyslexia. The reliability of the clinical eye movement tests and the efficacy of the eye movement therapies have not been determined. Saccades are the fast eye movements that move our eyes from one word to the next when we read. The eye movement recordings from patients diagnosed with reading disorders, extra ocular muscle imbalances and control patients (no learning disability or eye movement disorder) will be analyzed and compared. The sensitivity and specificity of detecting reading disorders will be determined for the Visagraph III and the Readalyzer. Although these clinical tests are frequently used to diagnose saccadic inaccuracies and diagnose dyslexia in school aged children, the validity of these clinical screening tests has not been determined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2013
CompletedFirst Posted
Study publicly available on registry
May 22, 2013
CompletedStudy Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedNovember 22, 2023
November 1, 2023
9 months
May 20, 2013
November 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Sensitivity and specificity of clinical eye movement devices
The primary analysis will be determining the sensitivity and specificity of the eye movement recording devices to recognize reading disorders. The sensitivity (true positive rate) of the eye movement recorders will be determined by the ability of each device to recognize children with reading disorders in Group 1. The specificity of the recorders will be determined by calculating the false positives in group 2 (eye movement disorders), and group 3 (control subjects).
June 2014
Secondary Outcomes (1)
Comparison of eye movement characteristics amongst patients with reading disorders, eye movement abnormalities and control subjects.
June 2014
Study Arms (3)
Children with reading disabilities
Children diagnosed with reading disabilities (age 7 to 13).
Children with eye movement disorders
Children diagnosed with eye movement disorders (age 7 to 13).
Control Group
Children with normal reading ability and normal eye movements (age 7 to 13.
Eligibility Criteria
Children with reading disorders, eye movement disorders or control (normal reading and eyemovements)between the ages of 7 and 13 are eligible for the study.
You may qualify if:
- \. Age 7 to 13 (Must be in at least 2nd grade, but not higher than 8th grade) 2. Complete ophthalmic examination performed by a pediatric ophthalmologist and orthoptist.
- \. All ocular structures must be within normal limits. 4. Best corrected visual acuity must be equal to or better than 20/30 in each eye.
- \. Group 1:
- Children with a reading disability must be given the diagnosis by a clinical educational specialist, educational psychologist or neuro-behavioral psychologist.
- Children with a reading disability may not have any ophthalmic anomaly determined by testing as described above. This includes but is not limited to amblyopia, strabismus, nystagmus, or any organic disease.
- \. Group 2
- a. Eye movement disorder confirmed by testing by a pediatric ophthalmologist and/or orthoptist b. All other ocular structures must be within normal limits (including visual acuity).
- \. Group 3:
- No evidence of reading disability, attention deficit disorder or ocular anomaly, including eye muscle or movement disorder as specified above.
You may not qualify if:
- \. Myopia more than - 6.00 diopters (spherical equivalent) in either eye. 2. Hyperopia more than + 6.00 diopters (spherical equivalent) in either eye. 3. History of vision therapy or orthoptic treatment 4. Any ocular anomaly with the exception of eye movement disorder for group 2.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Scripps Healthlead
Study Sites (1)
Scripps Clinic
San Diego, California, 92130, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregory Ostrow, MD
Scripps Clinic
- STUDY DIRECTOR
Laura Kirkeby, Orthoptics
Scripps Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Project Manager
Study Record Dates
First Submitted
May 20, 2013
First Posted
May 22, 2013
Study Start
December 1, 2013
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
November 22, 2023
Record last verified: 2023-11